Why is ALRT positioned for exponential growth? Look at these facts…
“The International Diabetes Federation (IDF) is the umbrella organization of over 200 national diabetes associations in over 160 countries. It represents the interests of the growing number of people with diabetes and those at risk. The Federation has been leading the global diabetes community since 1950, and IDF’s mission is to promote diabetes care, prevention, and a cure worldwide.
New figures from the 5th edition Diabetes Atlas (see http://www.idf.org/diabetesatlas) indicate that the number of people living with diabetes is expected to rise from 366 million in 2011 to 552 million by 2030. IDF also estimates that as many as 183 million people are unaware that they have diabetes.”
In the opinion Dr. Donald M. Berwick, the now former administrator of the Centers for Medicare and Medicaid Services (CMS), “Twenty percent to thirty percent of health spending is “waste” that yields no benefit to patients, and that some of the needless spending is a result of onerous, archaic regulations enforced by his agency.” The doctor’s estimates of this “waste” amounts to between $150 billion and $250 billion per year — monies that are desperately needed in reducing our country’s enormous debt problem and that could also go toward providing better health care service.
Finally, many electronic test strips are being sold illegally and the source of controversy and outrage over a waste of government funds. The Black Market offerings and the subsequent risks involved are not going to disappear on their own, nor will the exorbitant waste of funds relating to non-documented strip reimbursement. Fortunately, steps have been taken in the past to combat similar problems; such as when Medicare and many private insurers began mandating the verification of use for CPAP machines to allow reimbursement for sleep apnea. Given this precedent and the mounting awareness of strip count fraud, it is easy to envision the government taking similar actions to deal with the issues surrounding diabetes test strips. Such action would exponentially grow the usage of technologies such as the HeC System. Medicare provides coverage to 10.9 million diabetes patients and pays over $1 billion a year for test strips alone. With the financial pressures in the healthcare industry to regulate costs and provide better disease management, it would seem likely that further actions are imminent.
All of these factors leave ALR Technologies in the catbird seat and provide plenty of headroom for rapid growth in the short-term. Their Health-e-Connect System is the only technology of its kind that meets all the demands to help CMS control costs and encourage better disease management. Investors are encouraged to check out the ALRT blog to read more on these topics to better understand the complete picture of why this sleeper is so well-aligned to capitalize in 2012.
Founded and incorporated under the laws of the State of Nevada in 1998, ALR Technologies Inc. (OTCBB: ALRT) was established to address a growing need in the disease management industry for better patient compliance monitoring.
The ALRT Health-e-Connect (HeC) System is the principal product of the Company. HeC is a web-based patient management platform for medical professionals to improve compliance and management of care plans of patients in their homes. HeC is currently programmed to assist healthcare providers caring for diabetes patients. The platform will be expanded to cover patients with other chronic diseases.
HISTORY OF ALR TECHNOLOGIES, INC.
In 2003, ALR Technologies began marketing the ALRT Medication Reminder line of medication reminder devices. This line of manually programmable reminder devices was soon followed in the market by a PC programmable medication reminder device, the ALRT PC100. At this time, ALR Technologies also developed and introduced a line of medication and treatment reminder devices for the pet market. Named the ALRT Pet Reminder, this line of medication reminders was designed for use with veterinary pharmaceuticals for the prevention of heartworm disease in cats and dogs. By 2005, ALR Technologies’ next generation of PC programmable medication reminders was introduced into the market. Called the ALRT PC200, this device was developed to address the requirements of companies providing mail order medications and disease management services.
ALR Technologies, Inc. SEC Filings
SHARE STRUCTURE (approximate as of August, 2011)
Pacific Stock Transfer Company
4045 South Spencer St., Suite 403
Las Vegas, NV, 89119
7400 Beaufont Springs Dr.
Richmond, VA 23225
Email: [email protected]
Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has been compensated twenty thousand dollars per month for three months of consultation and journalism services and to manage a comprehensive investor relations/awareness program by ALR Technologies. Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.
Contacts and informationHave an opinion or news that you want to share?
Most popular categories